Skip to main content
ICLR logo
ICLR
(NASDAQ)
ICON Public Limited Company
$114.19-- (--)
Loading... - Market loading

ICON Public Limited Company (ICLR) Stock Price & Financial Analysis

ICON Public Limited Company Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$108.58 - $115.63
52-Week High$211.00
52-Week Low$66.57
Open$110.06
Volume660.59K
Average Volume (3M)660.59K
Market Cap8.92B
Shares Outstanding78.08M
P/E Ratio (TTM)14.51
Forward P/E18.11
Price to Sales (P/S)1.07
Price to Book (P/B)0.93
EV/EBITDA9.87
Revenue (TTM)8.10B
Net Income (TTM)599.48M
Free Cash Flow (TTM)964.18M
EPS (TTM)$7.68
Profit Margin7.40%
Operating Margin13.99%
Return on Equity (ROE)6.42%
Debt to Equity0.37
50-Day MA$123.88
200-Day MA$160.05
52-Week Change-33.11%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About ICON Public Limited Company

What is the current stock price for ICLR?

As of the latest trading session, ICLR stock trades at $114.19. The 52-week range is $66.57–$211.00, with a day range of $108.58–$115.63.

What is the P/E ratio for ICLR?

ICON Public Limited Company's trailing P/E ratio is 14.5, meaning investors pay $14.5 for every $1 of annual earnings. The forward P/E is 18.1, reflecting analyst expectations for future earnings. ICON Public Limited Company operates in the Healthcare sector.

Does ICLR pay dividends?

ICON Public Limited Company does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ICLR?

Based on 13 analysts, the consensus for ICLR is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ICLR?

ICON Public Limited Company's market capitalization is $8.92B, classifying it as a mid-cap company. ICON Public Limited Company operates in the Healthcare sector within the Diagnostics & Research industry.